Sign In

Login

Password

Forgot Password ? Sign Up

Nicergolina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nicergolina" in Italian language version.

refsWebsite
Global rank Italian rank
22nih.gov
4th place
9th place
3oadoi.org
799th place
22nd place
3doi.org
2nd place
7th place
1agenziafarmaco.gov.it
low place
1,603rd place

agenziafarmaco.gov.it

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • AM. Huchet, P. Mouillé; J. Chelly; B. Lucet; MF. Doursout; P. Lechat; H. Schmitt, Effects of nicergoline on the cardiovascular system of dogs and rats., in J Cardiovasc Pharmacol, vol. 3, n. 4, pp. 677-91, PMID 6167799.
  • A. Moretti, N. Carfagna; C. Caccia; M. Carpentieri, Effect of ergolines on neurotransmitter systems in the rat brain., in Arch Int Pharmacodyn Ther, vol. 294, pp. 33-45, PMID 2906797.
  • M. Le Poncin-Lafitte, C. Grosdemouge; D. Duterte; JR. Rapin, Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline., in Gerontology, vol. 30, n. 2, 1984, pp. 109-19, PMID 6706123.
  • G. Blasco, U. Traversa; F. Drago, Effects of nicergoline on rabbit electroretinogram during recovery after ischaemia in light and dark., in Pharmacol Res, vol. 36, n. 5, Nov 1997, pp. 363-8, DOI:10.1006/phrs.1997.0240, PMID 9441726.
  • K. Takahashi, N. Akaike, Nicergoline inhibits T-type Ca2+ channels in rat isolated hippocampal CA1 pyramidal neurones., in Br J Pharmacol, vol. 100, n. 4, Ago 1990, pp. 705-10, PMID 2169937.
  • E. Iwata, I. Miyazaki; M. Asanuma; A. Iida; N. Ogawa, Protective effects of nicergoline against hydrogen peroxide toxicity in rat neuronal cell line., in Neurosci Lett, vol. 251, n. 1, Lug 1998, pp. 49-52, PMID 9714462.
  • A. Moretti, G. Arcari; L. Pegrassi, [A review of pharmacological studies on nicergoline]., in Arzneimittelforschung, vol. 29, 8a, 1979, pp. 1223-7, PMID 44197.
  • SY. Kim, JS. Choi; CK. Joo, Effects of nicergoline on corneal epithelial wound healing in rat eyes., in Invest Ophthalmol Vis Sci, vol. 50, n. 2, Feb 2009, pp. 621-5, DOI:10.1167/iovs.08-2037, PMID 18836171.
  • BW. Neumann, F. Leuschner, [Experimental animal studies on nicergoline tolerance]., in Arzneimittelforschung, vol. 29, 8a, 1979, pp. 1206-13, PMID 540065.
  • J. Dauverchain, [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)]., in Arzneimittelforschung, vol. 29, 8a, 1979, pp. 1308-10, PMID 395956.
  • A. Battaglia, G. Bruni; A. Ardia; G. Sacchetti, Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study., in J Am Geriatr Soc, vol. 37, n. 4, Apr 1989, pp. 295-302, PMID 2646350.
  • B. Saletu, E. Paulus; L. Linzmayer; P. Anderer; HV. Semlitsch; J. Grünberger; L. Wicke; A. Neuhold; I. Podreka, Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study., in Psychopharmacology (Berl), vol. 117, n. 4, Feb 1995, pp. 385-95, PMID 7604138.
  • WM. Herrmann, K. Stephan; K. Gaede; M. Apeceche, A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia., in Dement Geriatr Cogn Disord, vol. 8, n. 1, pp. 9-17, PMID 8997547.
  • RG. Fariello, Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art., in Funct Neurol, vol. 12, n. 3-4, pp. 221-5, PMID 9218984.
  • A. Baskys, AC. Hou, Vascular dementia: pharmacological treatment approaches and perspectives., in Clin Interv Aging, vol. 2, n. 3, 2007, pp. 327-35, PMID 18044183.
  • M. Fioravanti, L. Flicker, Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment., in Cochrane Database of Systematic Reviews, n. 4, 2001, pp. CD003159, DOI:10.1002/14651858.CD003159, PMID 11687175.
  • F. Forette, D. Varin; JF. Henry; MP. Hervy, [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)]., in Nouv Presse Med, vol. 9, n. 48, Dic 1980, pp. 3685-8, PMID 7005872.
  • JA. Levenson, E. Roland; J. Toto Mou Kouo; A. Simon; M. Safar, [Intravenous effect of nicergoline in arterial hypertension]., in Rev Med Interne, vol. 1, n. 1, 1980, pp. 123-6, PMID 7232904.
  • M. Borgioli, E. Merendino; B. Ricci, [Therapeutic efficacy of nicergoline in ophthalmology. Fluorescence retinographic study (author's transl)]., in Arzneimittelforschung, vol. 29, 8a, 1979, pp. 1311-6, PMID 540076.
  • JP. Rivory, H. Maheut, [Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alpha-adrenergic system?]., in Presse Med, vol. 13, n. 44, Dic 1984, p. 2703, PMID 6096843.
  • B. Winblad, M. Fioravanti; T. Dolezal; I. Logina; IG. Milanov; DC. Popescu; A. Solomon, Therapeutic use of nicergoline., in Clin Drug Investig, vol. 28, n. 9, 2008, pp. 533-52, PMID 18666801.
  • F. Boismare, N. Moore; S. Decourt; G. Paux; C. Saligaut; P. Chretien, Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol., in Methods Find Exp Clin Pharmacol, vol. 5, n. 2, 1983, pp. 83-8, PMID 6876944.

oadoi.org